In contrast, our study enabled prioritizing 138 genes based on a refined set of putative somatic SNVs, where 49 of those genes had previously been related to kidney cancer according to the literature, and two genes (SIPA1L2 and EIF3A) were validated in independent datasets from TCGA. This evidence concerns the gene SIPA1L2 and kidney cancer.